Burning Rock Biotech (BNR) Non-Current Assets (2021 - 2023)

Burning Rock Biotech has reported Non-Current Assets over the past 3 years, most recently at $21.7 million for Q4 2023.

  • Quarterly results put Non-Current Assets at $21.7 million for Q4 2023, down 53.15% from a year ago — trailing twelve months through Dec 2023 was $21.7 million (down 53.15% YoY), and the annual figure for FY2023 was $22.0 million, down 55.15%.
  • Non-Current Assets for Q4 2023 was $21.7 million at Burning Rock Biotech, down from $46.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BNR hit a ceiling of $71.6 million in Q4 2021 and a floor of $21.7 million in Q4 2023.
  • Median Non-Current Assets over the past 3 years was $46.2 million (2022), compared with a mean of $46.5 million.
  • Biggest five-year swings in Non-Current Assets: plummeted 35.43% in 2022 and later crashed 53.15% in 2023.
  • Burning Rock Biotech's Non-Current Assets stood at $71.6 million in 2021, then plummeted by 35.43% to $46.2 million in 2022, then crashed by 53.15% to $21.7 million in 2023.
  • The last three reported values for Non-Current Assets were $21.7 million (Q4 2023), $46.2 million (Q4 2022), and $71.6 million (Q4 2021) per Business Quant data.